NEW YORK (GenomeWeb News) – Pacific Biomarkers today said that it will collaborate with India-based Clinigene International on addressing the biomarker and high-end clinical trial services needs of the pharmaceutical and biotech industry.
Seattle-based Pacific Biomarkers provides biomarker and diagnostic assay services. Among Clinigene's services are cell-based assays and immunoanalytical testing.
"This partnership with Clinigene provides us access to India, an emerging hub for drug development and contract research," Pacific Biomarkers CEO Ronald Helm said in a statement. "Further, Clinigene's state-of-the-art facilities and highly qualified staff help us offer to all of our clients an economic option for conducting their biomarker and specialty clinical lab tests."
Further terms of the alliance were not disclosed.